SCHEMBL6677987

SCHEMBL6677987

COc1cccc(C2=C/C(=C\c3ccc(F)cc3)CCC2CN(C)C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 3/20 0.48
CCR6 P51684 2/20 0.48
NFE2L2 Q16236 1/20 0.39
NPY5R Q15761 1/20 0.36
MITF O75030 1/20 0.36
EGFR P00533 1/20 0.34
HTR1A P08908 1/20 0.34
HTR7 P34969 1/20 0.34
MAOB P27338 1/20 0.34
SLC6A2 P23975 3/20 0.34
SLC6A4 P31645 3/20 0.34
OPRM1 P35372 3/20 0.34
SLC22A1 O15245 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
CHRM2 P08172 1/20 0.34
CHRM1 P11229 1/20 0.34
OPRD1 P41143 1/20 0.34
OPRK1 P41145 1/20 0.34
KCNA5 P22460 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6721137 1.00 HSP90AA1 (0.48) HSP90AA1CCR6NFE2L2NPY5RMITF
SCHEMBL6677339 1.00 HSP90AA1 (0.48) HSP90AA1CCR6NFE2L2NPY5RMITF
SCHEMBL6727331 1.00 HSP90AA1 (0.48) HSP90AA1CCR6NFE2L2NPY5RMITF
SCHEMBL6683488 1.00 HSP90AA1 (0.48) HSP90AA1CCR6NFE2L2NPY5RMITF
SCHEMBL6677990 0.90 CCR6 (0.48) HSP90AA1CCR6NFE2L2MITFEGFR
SCHEMBL6718866 0.90 CCR6 (0.48) HSP90AA1CCR6NFE2L2MITFEGFR
SCHEMBL6681695 0.90 CCR6 (0.48) HSP90AA1CCR6NFE2L2MITFEGFR
SCHEMBL6677991 0.90 CCR6 (0.48) HSP90AA1CCR6NFE2L2MITFEGFR
SCHEMBL6727332 0.86 NFE2L2 (0.39) HSP90AA1CCR6NFE2L2NPY5REGFR
SCHEMBL6721138 0.86 NFE2L2 (0.39) HSP90AA1CCR6NFE2L2NPY5REGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1246793-B1 SUBSTITUTED AMINOMETHYL-PHENYL-CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2004-11-10 EP claimed
US-6673794-B2 ANALGESICS, INCOTINENCE, SKIN DISORDERS, ANTIINFLAMMATORY AGENTS GRUENENTHAL GMBH (DE) 2004-01-06 US claimed
US-20030069288-A1 Substituted aminomethyl-phenyl-cyclohexane derivatives GRUENETHAL GMBH (DE) 2003-04-10 US claimed
EP-1246793-B1 SUBSTITUTED AMINOMETHYL-PHENYL-CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2004-11-10 EP disclosed
US-6673794-B2 ANALGESICS, INCOTINENCE, SKIN DISORDERS, ANTIINFLAMMATORY AGENTS GRUENENTHAL GMBH (DE) 2004-01-06 US disclosed
US-20030069288-A1 Substituted aminomethyl-phenyl-cyclohexane derivatives GRUENETHAL GMBH (DE) 2003-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069288-A1 Substituted aminomethyl-phenyl-cyclohexane derivatives PTGER1, CYP2E1, HRH2 HSP90AA1 1652/4885CCR6 1317/4885NFE2L2 1085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.